Daniëlle R.M. Timmermans comments on an article about individualisation of prevention on ntvg.nl:
Even more so than in the treatment of diseases, it is of importance in the case of preventive medication that a proper balance is found between the advantages and disadvantages for individuals. Individualisation of the prediction of risks of disease and treatment effects is therefore a good development. But what will this mean for patients in practice?